349 related articles for article (PubMed ID: 32274740)
21. Heparanase: one molecule with multiple functions in cancer progression.
Vlodavsky I; Elkin M; Abboud-Jarrous G; Levi-Adam F; Fuks L; Shafat I; Ilan N
Connect Tissue Res; 2008; 49(3):207-10. PubMed ID: 18661344
[TBL] [Abstract][Full Text] [Related]
22. Heparanase uptake is mediated by cell membrane heparan sulfate proteoglycans.
Gingis-Velitski S; Zetser A; Kaplan V; Ben-Zaken O; Cohen E; Levy-Adam F; Bashenko Y; Flugelman MY; Vlodavsky I; Ilan N
J Biol Chem; 2004 Oct; 279(42):44084-92. PubMed ID: 15292202
[TBL] [Abstract][Full Text] [Related]
23. Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development.
Vlodavsky I; Goldshmidt O; Zcharia E; Atzmon R; Rangini-Guatta Z; Elkin M; Peretz T; Friedmann Y
Semin Cancer Biol; 2002 Apr; 12(2):121-9. PubMed ID: 12027584
[TBL] [Abstract][Full Text] [Related]
24. [Research advancement on heparanase in tumor metastasis].
Li ZH; Yang SM
Ai Zheng; 2005 Sep; 24(9):1156-60. PubMed ID: 16159446
[TBL] [Abstract][Full Text] [Related]
25. Characterization of heparanase from a rat parathyroid cell line.
Podyma-Inoue KA; Yokote H; Sakaguchi K; Ikuta M; Yanagishita M
J Biol Chem; 2002 Sep; 277(36):32459-65. PubMed ID: 12077130
[TBL] [Abstract][Full Text] [Related]
26. The Development of Assays for Heparanase Enzymatic Activity: Towards a Gold Standard.
Chhabra M; Ferro V
Molecules; 2018 Nov; 23(11):. PubMed ID: 30441818
[TBL] [Abstract][Full Text] [Related]
27. The heparanase/syndecan-1 axis in cancer: mechanisms and therapies.
Ramani VC; Purushothaman A; Stewart MD; Thompson CA; Vlodavsky I; Au JL; Sanderson RD
FEBS J; 2013 May; 280(10):2294-306. PubMed ID: 23374281
[TBL] [Abstract][Full Text] [Related]
28. Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy.
Sanderson RD; Elkin M; Rapraeger AC; Ilan N; Vlodavsky I
FEBS J; 2017 Jan; 284(1):42-55. PubMed ID: 27758044
[TBL] [Abstract][Full Text] [Related]
29. Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug Resistance.
Lanzi C; Zaffaroni N; Cassinelli G
Curr Med Chem; 2017; 24(26):2860-2886. PubMed ID: 28215163
[TBL] [Abstract][Full Text] [Related]
30. Hyperpigmentation in human solar lentigo is promoted by heparanase-induced loss of heparan sulfate chains at the dermal-epidermal junction.
Iriyama S; Ono T; Aoki H; Amano S
J Dermatol Sci; 2011 Dec; 64(3):223-8. PubMed ID: 22005029
[TBL] [Abstract][Full Text] [Related]
31. Multi-faceted substrate specificity of heparanase.
Peterson SB; Liu J
Matrix Biol; 2013 Jun; 32(5):223-7. PubMed ID: 23499529
[TBL] [Abstract][Full Text] [Related]
32. PI-88 and Related Heparan Sulfate Mimetics.
Chhabra M; Ferro V
Adv Exp Med Biol; 2020; 1221():473-491. PubMed ID: 32274723
[TBL] [Abstract][Full Text] [Related]
33. Non-Anticoagulant Heparins as Heparanase Inhibitors.
Cassinelli G; Torri G; Naggi A
Adv Exp Med Biol; 2020; 1221():493-522. PubMed ID: 32274724
[TBL] [Abstract][Full Text] [Related]
34. Heparanase - Discovery and Targets.
Lindahl U; Li JP
Adv Exp Med Biol; 2020; 1221():61-69. PubMed ID: 32274706
[TBL] [Abstract][Full Text] [Related]
35. Versatile role of heparanase in inflammation.
Goldberg R; Meirovitz A; Hirshoren N; Bulvik R; Binder A; Rubinstein AM; Elkin M
Matrix Biol; 2013 Jun; 32(5):234-240. PubMed ID: 23499528
[TBL] [Abstract][Full Text] [Related]
36. Heparanase: A Novel Therapeutic Target for the Treatment of Atherosclerosis.
Nguyen TK; Paone S; Chan E; Poon IKH; Baxter AA; Thomas SR; Hulett MD
Cells; 2022 Oct; 11(20):. PubMed ID: 36291066
[TBL] [Abstract][Full Text] [Related]
37. Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity.
Baburajeev CP; Mohan CD; Rangappa S; Mason DJ; Fuchs JE; Bender A; Barash U; Vlodavsky I; Basappa ; Rangappa KS
BMC Cancer; 2017 Mar; 17(1):235. PubMed ID: 28359266
[TBL] [Abstract][Full Text] [Related]
38. The potential of heparanase as a therapeutic target in cancer.
Pisano C; Vlodavsky I; Ilan N; Zunino F
Biochem Pharmacol; 2014 May; 89(1):12-9. PubMed ID: 24565907
[TBL] [Abstract][Full Text] [Related]
39. Involvement of heparanase in migration of microglial cells.
Takahashi H; Matsumoto H; Smirkin A; Itai T; Nishimura Y; Tanaka J
Biochim Biophys Acta; 2008 Apr; 1780(4):709-15. PubMed ID: 18222122
[TBL] [Abstract][Full Text] [Related]
40. Heparan sulfate and heparanase as modulators of breast cancer progression.
Gomes AM; Stelling MP; Pavão MS
Biomed Res Int; 2013; 2013():852093. PubMed ID: 23984412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]